New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Tuberculosis (TB) is a bacterial infection. It most commonly causes a lung infection after a period of no disease activity, with symptoms such as coughing, chest pain, and fatigue.

Picking up where traditional antibiotics are failing, two natural compounds have been shown effective in killing ...

Without access to diagnostics and medicines, TB will affect tens of thousands more with drug-resistant bacteria, which will become untreatable.

Tuberculosis. Read the latest research news on tuberculosis, including a quick new TB test, new TB treatment options, and the latest news on tuberculosis infections.

public health As counsellors, they help fellow TB patients recover. Now a fund squeeze has left them high and dry The ‘TB Champions’ programme is a vital part of India’s fight to eliminate ...

By targeting a previously unexploited metabolic pathway essential for bacterial survival, the drug candidate may offer the potential to develop safer, shorter and more effective treatment regimens ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

Crucially, the researchers found that in the bacteria studied, geosmin and 2-MIB were produced only by colonies that were also producing reproductive spores.